WhatsApp
X
LinkedIn
Facebook
BlueSky
Telegram
Among several moves, Singapore will establish a priority track assessing selected innovative health products, says Health Minister Ong Ye Kung
Source Articles
Good medical innovations reach patients sooner with good regulation: Ong Ye Kung
Straits Times (Singapore) | Oct 12, 2026
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 statements to vote on •
Your perspective shapes the analysis
📊 Progress to Consensus Analysis
Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants
0/7
Statements (10+ recommended)
10/10
Total Votes
0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.
Your votes count
No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.
CLAIM
Posted by admin
•
Oct 12, 2026
The regulation of healthcare innovations should prioritize the long-term health outcomes of patients over market speed.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Patient feedback should be integrated into the regulatory process for healthcare innovations to ensure they meet real needs.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Singapore should adopt a risk-based approach to regulation that allows faster access to lower-risk innovations.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Healthcare regulations should prioritize patient safety while fostering innovation in Singapore.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Innovation should not come at the expense of thorough clinical trials and safety evaluations for new health products.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
The Singaporean government must ensure that healthcare innovation does not compromise the quality of patient care.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Regulatory bodies must have the resources to effectively assess and monitor innovative healthcare products post-approval.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Regulations must be stringent to ensure that innovative healthcare products are safe and effective for patients.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Patients should have the right to access experimental treatments under controlled conditions even if they are not fully approved.
Vote to see results
CLAIM
Posted by admin
•
Oct 12, 2026
Patient feedback should play a crucial role in shaping the regulatory landscape for healthcare innovations in Singapore.
Vote to see results
💡 How This Works
- • Add Statements: Post claims or questions (10-500 characters)
- • Vote: Agree, Disagree, or Unsure on each statement
- • Respond: Add detailed pro/con responses with evidence
- • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us